Posts By: pharmanewsdaily

FDA approves ApiFix MID-C system for progressive AIS

Israeli medical devices manufacturer ApiFix has bagged approval from the US Food and Drug Administration (FDA) for marketing its minimally invasive deformity correction system (MID-C system) or the treatment of progressive adolescent idiopathic scoliosis (AIS) through a humanitarian device exemption (HDE). Considered to be the most common form of scoliosis, adolescent idiopathic scoliosis impacts 2-3% […]

Gilead Sciences bags Descovy FDA approval for prevention of HIV infection

Descovy FDA approval : Gilead Sciences’ Descovy (emtricitabine 200 mg and tenofovir alafenamide 25 mg tablets; F/TAF) has been approved by the US Food and Drug Administration for HIV Pre-Exposure Prophylaxis (PrEP) or in other words prevention of HIV infection.. PrEP is defined as an HIV prevention method in which medicine is taken everyday before […]

AdaptHealth to acquire Patient Care Solutions from McKesson

AdaptHealth, a US home medical equipment provider (HME provider), has agreed to acquire the Patient Care Solutions business from German healthcare and pharma company McKesson. Patient Care Solutions offers wound care supplies, urological supplies, ostomy supplies, incontinence supplies, breast pumps, and diabetic care supplies to patients across 50 states in the US. For the 12 […]

ImmersiveTouch launches ImmersiveView 3.0 VR imaging platform for radiology

ImmersiveTouch, a US medical technology company, has introduced a new virtual reality imaging platform (VR imaging platform) called ImmersiveView 3.0 that enables physicians to combine patient computed tomography (CT), VR and magnetic resonance (MR), all at the same time to personalize surgeries. ImmersiveView 3.0 is said to have a high degree of accuracy in combination […]

Innovent Biologics begins phase 1 trial of IBI315 in solid malignancies

Innovent Biologics and Beijing Hanmi Pharmaceutical, a subsidiary of Hanmi Pharmaceutical, said that the first patient has been dosed in a phase 1 clinical trial in China for evaluating IBI315 for the treatment of advanced solid malignancies. IBI315, which has been co-developed by the companies, is a recombinant fully human bispecific antibody targeting programmed cell […]

Global Blood Therapeutics bags Oxbryta FDA approval for sickle cell disease

Oxbryta FDA approval : Global Blood Therapeutics (GBT), a California-based biopharma company, has bagged approval for Oxbryta (voxelotor) tablets from the US Food and Drug Administration (FDA) for sickle cell disease (SCD). The FDA approval of Oxbryta is for the treatment of adults and children, aged 12 years of age and older, who are suffering […]

Gsport creates cohesive bandages for human and animal patients

Gsport, a Chinese sports medicine company claims to have created high-quality cohesive bandages for human and animal patients. The company, which manufactures therapeutic products in its Zhejiang facility, has expanded its business into the US. Its products range from cold bags, athletic tape, and kinesiology tape for athletic care. All the athletic care products are […]

Ferring, Blackstone invest $570m in nadofaragene firadenovec gene therapy

Ferring Pharmaceuticals, a Swiss specialty biopharmaceutical group, has teamed up with private investment platform Blackstone Life Sciences to jointly invest more than $570 million in nadofaragene firadenovec (rAd-IFN/Syn3), an investigational gene therapy. Currently, nadofaragene firadenovec is in late-stage development for the treatment of patients with high-grade, Bacillus Calmette-Guérin (BCG) unresponsive, non-muscle invasive bladder cancer (NMIBC). […]

Novartis to acquire The Medicines Company for $9.7bn with eye on inclisiran

Novartis acquisition of The Medicines Company : Swiss drugmaker Novartis signed a deal worth $9.7 billion to acquire US biopharma company The Medicines Company, as per the latest pharma acquisition news. As per the terms of the all-cash deal, Novartis will acquire The Medicines Company for $85.00 per share. The Medicines Company, which is headquartered […]

Scroll To Top